Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Transfer Program for Transitioning From Exubera® (Insulin Human [rDNA Origin]) Inhalation Powder to Technosphere® Insulin (Insulin Human [rDNA Origin]) Inhalation Powder

NCT01798914 is registered in ClinicalTrials.gov with Mannkind Corporation as lead sponsor.

NCT NCT01798914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01798914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Transfer Program for Transitioning From Exubera® (Insulin Human [rDNA Origin]) Inhalation Powder to Technosphere® Insulin (Insulin Human [rDNA Origin]) Inhalation Powder
Lead sponsor
Mannkind Corporation
Phase
Expanded access
Overall status
No longer available
Start date
October 31, 2008
Completion date
May 31, 2015
Enrollment
Not reported
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes